Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124225 | SCV000167646 | benign | not specified | 2013-02-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000124225 | SCV000342319 | benign | not specified | 2016-06-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000524566 | SCV000639469 | benign | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316345 | SCV000851896 | benign | Inborn genetic diseases | 2018-01-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003436941 | SCV004166655 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | CDKL5: BP4, BP7 |
Breakthrough Genomics, |
RCV003436941 | SCV005274370 | benign | not provided | criteria provided, single submitter | not provided |